PDCD1 and cancer: BCA patients who were positive for PD1 had a 5.194-fold higher risk of death (95% CI, 2.779–9.706) and a 3.188-fold higher risk of death or cancer relapse (95% CI: 1.993–5.099) compared to BCA patients who were negative for PD1 (Table 1).